ArticleScience translational medicine2023

Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.

Yasutaka Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.